These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22862565)

  • 1. The spread of vaccine-preventable diseases by international travellers: a public-health concern.
    Gautret P; Botelho-Nevers E; Brouqui P; Parola P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():77-84. PubMed ID: 22862565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pre-travel vaccine-preventable disease serology as a screening tool to identify patients in need of pre-travel vaccination: a retrospective audit.
    Turner DP; McGuinness SL; Cohen J; Waring LJ; Leder K
    J Travel Med; 2017 May; 24(3):. PubMed ID: 28355621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-preventable diseases in Europe: where do we stand?
    Wicker S; Maltezou HC
    Expert Rev Vaccines; 2014 Aug; 13(8):979-87. PubMed ID: 24958075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of vaccine preventable diseases at large events.
    Alqahtani AS; Alfelali M; Arbon P; Booy R; Rashid H
    Vaccine; 2015 Nov; 33(48):6552-63. PubMed ID: 26437018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 Rugby World Cup and 2020 Summer Olympic and Paralympic Games.
    Griffith MM; Fukusumi M; Kobayashi Y; Matsui Y; Nishiki S; Shimbashi R; Morino S; Sunagawa T; Tanaka-Taya K; Matsui T; Oishi K
    Western Pac Surveill Response J; 2018; 9(2):26-33. PubMed ID: 30057855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Global spread of meningococcal serogroup W135].
    Vestergård D; David KP
    Ugeskr Laeger; 2008 Sep; 170(39):3044-7. PubMed ID: 18822228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A closer look at travellers' infections abroad: Finnish nationwide data with incidences, 2010 to 2012.
    Siikamäki H; Kivelä P; Fotopoulos M; Kantele A
    Travel Med Infect Dis; 2017; 15():29-36. PubMed ID: 27773779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations.
    Lam E; McCarthy A; Brennan M
    Hum Vaccin Immunother; 2015; 11(11):2627-36. PubMed ID: 26406333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet.
    Lammert SM; Rao SR; Jentes ES; Fairley JK; Erskine S; Walker AT; Hagmann SH; Sotir MJ; Ryan ET; LaRocque RC
    J Travel Med; 2016 Jul; 24(1):. PubMed ID: 27799502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes--Bangladesh, China, and India, 2006-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(49):1008-11. PubMed ID: 23235298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Travel vaccinations].
    Rothe C; Boecken G;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):74-84. PubMed ID: 31802155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013.
    Dahl V; Wallensten A
    PLoS One; 2017; 12(7):e0181625. PubMed ID: 28753671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccines inf the prevention of fecal hazards].
    Saliou P
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adult immunization in France: an update].
    Beytout J; Laurichesse H
    Rev Prat; 2004 Mar; 54(5):499-505. PubMed ID: 15176507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliomyelitis--prevention in travellers.
    Mayer CA; Neilson AA
    Aust Fam Physician; 2010 Mar; 39(3):122-5. PubMed ID: 20369113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Business travelers: vaccination considerations for this population.
    Chen LH; Leder K; Wilson ME
    Expert Rev Vaccines; 2013 Apr; 12(4):453-66. PubMed ID: 23560925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B risks and immunisation coverage amongst Australians travelling to southeast Asia and east Asia.
    Leggat PA; Zwar NA; Hudson BJ;
    Travel Med Infect Dis; 2009 Nov; 7(6):344-9. PubMed ID: 19945011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network.
    Boggild AK; Castelli F; Gautret P; Torresi J; von Sonnenburg F; Barnett ED; Greenaway CA; Lim PL; Schwartz E; Wilder-Smith A; Wilson ME;
    Vaccine; 2010 Oct; 28(46):7389-95. PubMed ID: 20851081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006–2010.
    Krishnarajah G; Carroll C; Priest J; Arondekar B; Burstin S; Levin M
    Hum Vaccin Immunother; 2014; 10(8):2460-7. PubMed ID: 25424956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.